期刊文献+

浅析医院人血白蛋白临床合理用药管理 被引量:4

Analysis on Clinical Application of Human Albumin in Guangxi Guidong People′s Hospital
下载PDF
导出
摘要 目的 调研我院人血白蛋白的使用情况,为完善医院人血白蛋白临床合理用药管理提供参考.方法 取我院2013年应用人血白蛋白的住院患者病历,对患者年龄、科室分布、用量、用药理由、用药前血清白蛋白浓度等进行统计与分析,并与人血白蛋白说明书和美国大学医院联合会关于人血白蛋白的使用标准进行比较.结果 我院15个临床科室涉及15类疾病使用人血白蛋白,用量较大的主要是肝胆疾病的患者;在个人用量分布方面,以使用30~40 g的患者最多;用药理由以低蛋白血症所占比例最大,达51.66%;使用人血白蛋白前患者血清白蛋白分布主要集中在21~30 g·L-1范围内.结论 医院人血白蛋白的使用较广泛,且存在不合理使用的可能性,须加强人血白蛋白使用各环节的监管,提高合理用药水平. Objective To investigate and study the application of human albumin in our hospital, in order to provide reference for the rational clinical drug use management. Methods Medical records of patients administered with human albumin in our hospital in 2013 were collected, and statistical analysis was conducted on the age of patients, department distribution, dosage, medication and serum albumin concentration before medication. The results were then compared with human albumin instructions as well as its usage standard defined by the USA University Hospital Consortium. Results In the 15 clinical departments of our hospital, human albumin was administrated in treatment of 15 diseases, and patients with hepatobiliary disease tended to have large consumptions; in the aspect of personal dosage distribution, most patients used 30-40 g; medication due to hypoproteinemia accounted for the largest proportion, up to 51.66% ; the serum albumin concentrations in patients before administration of human albumin were mainly in the range of 21-30 g · L^-1. Conclusion There was a wide use of human albumin in the hospital, with possibility of irrational use. Therefore it is necessary to strengthen the supervision, and to improve the level of rational use of human albumin.
出处 《中国药事》 CAS 2014年第8期904-907,共4页 Chinese Pharmaceutical Affairs
关键词 人血白蛋白 临床合理用药 医院用药管理 病历分析 human serum albumin clinical rational drug use hospital medicine management medical record analysis
  • 相关文献

参考文献7

二级参考文献61

  • 1王强,李大魁,张嫄.人血白蛋白临床应用的药物利用评价[J].中国药学杂志,2005,40(13):1036-1038. 被引量:37
  • 2李向阳,王为忠,王家林.腹部外科术后肠外营养支持时补充外源性白蛋白的研究[J].陕西医学杂志,2006,35(4):451-453. 被引量:20
  • 3卜一珊.人血白蛋白不良反应分析[J].天津药学,2007,19(1):35-37. 被引量:12
  • 4刘芳,翟所迪,田荣萍.临床应用人血白蛋白的循证医学评价[J].中国药学杂志,2007,42(6):478-480. 被引量:46
  • 5Koretz RL. Intravenous album and nutrition support:going for the quick fix [ J ]. J Parenter Enteral Nutr, 1995,19 (2) : 166-171.
  • 6Qulinlan GJ, Martin GS, evans TW. Albumin : biochemical properties and thereapeutic pocencial [ J]. Hepatology,2005,41 (6) :1211-1219.
  • 7Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation [ J ]. Cochrane Database Syst Rcv, 2003, (1): CD001319.
  • 8Bar-Or D, Bar-Or R, Rael LT, et al. Heterogeneity and oxidation status of commercial albumin preparations in clinical use [J].Crit Care Med,2005,33(7) :1638-1641.
  • 9Tanzi M,Gardner M,Megcllas M,et al. Evaluation of the appropriate use of albumin in adult and pediatric patients[J].Am J Health Syst Pharm ,2003,60( 13 ) : 1330-1335.
  • 10Vermeulen LC, Ratko TA, Erstad BL. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions[J]. Arch lntern Med, 1995,155(4) : 373.

共引文献72

同被引文献37

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部